2016
DOI: 10.1007/s12328-016-0656-5
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis and treatment of microscopic colitis

Abstract: Microscopic colitis (MC) designates two types of chronic diarrhea diseases, which are lymphocytic colitis and collagenous colitis. The prevalence of microscopic colitis is increasing in both Western and Eastern countries, possibly due to the high incidence of colonoscopic survey in chronic diarrhea patients. Although the overall prognosis of MC patients is mostly good, it should be noted that appropriate diagnosis and choice of treatment is required to assure a good clinical outcome for MC patients. Also, a ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
20
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 50 publications
0
20
0
1
Order By: Relevance
“…Several medications have been associated with drug induced microscopic colitis. Proton-pump inhibitors (PPI) appear to have the strongest association [5]. In a study done by Beaugerie and Pardi, 10 medications including PPIs, Non steroidal anti inflammatory drugs (NSAIDs), and selective serotonin receptor inhibitors (SSRIs) were ranked as high-risk drugs for developing MC [8].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Several medications have been associated with drug induced microscopic colitis. Proton-pump inhibitors (PPI) appear to have the strongest association [5]. In a study done by Beaugerie and Pardi, 10 medications including PPIs, Non steroidal anti inflammatory drugs (NSAIDs), and selective serotonin receptor inhibitors (SSRIs) were ranked as high-risk drugs for developing MC [8].…”
Section: Discussionmentioning
confidence: 99%
“…In mild cases, discontinuation of medications and use of anti diarrheal medications can lead to resolution [5]. Data from randomized trials indicates that Budesonide (9mg up to 8 weeks) increased the probability of experiencing clinical remission by 152% after 6 to 8 months of follow-up (RR, 2.52; 95% CI, 1.45-4.4).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The diagnosis of MC and assessment should begin from the onset of clinical symptoms (chronic or intermittent relapsing watery, non-bloody diarrhea) (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014). If such a symptom appears in a woman over the age of 50, diagnosis of MC should be highly suspected (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014). Also, if there is a newly started drug or a concomitant autoimmune disease will support the possible diagnosis of MC (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014).…”
mentioning
confidence: 99%
“…If such a symptom appears in a woman over the age of 50, diagnosis of MC should be highly suspected (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014). Also, if there is a newly started drug or a concomitant autoimmune disease will support the possible diagnosis of MC (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014). Diagnosis of MC depends on a proper medical history, with the exclusion of other diseases, background disease, drug consumption history, normal radiological, normal or almost normal endoscopic findings and endoscopic biopsies with histopathological findings consistent with MC (Macaigne et al 2014) (Okamoto et al 2016) (Ingle 2014).…”
mentioning
confidence: 99%